Results 201 to 210 of about 82,921 (264)

Expression and prognostic value of FKBP51 in Hodgkin lymphoma. [PDF]

Front Immunol
Varricchio S, Romano S, Russo D, Travaglino A, Cappiello R, Cervasio M, Ilardi G, Marrone L, Pane F, Picardi M, Persico M, Vigliar E, Acanfora G, Romano MF, Mascolo M.   +14 more
europepmc   +1 more source

Impaired hematopoiesis affects apheresis and CAR T‐cell product composition and treatment response

Transfusion, EarlyView.
Abstract Background Chimeric antigen receptor (CAR) T‐cell therapy has transformed the treatment of hematologic malignancies, but its success depends on obtaining sufficient CD3+ T‐cell yields during leukapheresis. This can be difficult in heavily pretreated patients, who often show leukopenia and reduced T‐cell fitness.
Hanna Kuhn, Felix Korell, Angela Hückelhoven‐Krauss, Brigitte Neuber, Miriam Stenzinger, Anita Ludwig‐Husemann, Maria‐Luisa Schubert, Patrick Derigs, Kiavasch Farid, Tim Sauer, Sandra Sauer, Carsten Müller‐Tidow, Peter Dreger, Michael Schmitt, Anita Schmitt   +14 more
wiley   +1 more source

Geospatial Access to CAR-T Clinical Trials for Non-Hodgkin Lymphoma for Persons With HIV.

JAMA Netw Open
Maillie L, Sisk M, Coghill AE, Van Bibber N, Guerra CE, Aboulafia DM, Atkinson TM, Velazquez V, Barta SK.   +8 more
europepmc   +1 more source

Secondary primary malignancies in indolent non-Hodgkin lymphoma patients receiving frontline bendamustine-rituximab. [PDF]

Cancer
Davies GA, Prica A, Ante Z, Liu N, Pond GR, Balitsky AK, Suleman A, Mozessohn L.   +7 more
europepmc   +1 more source

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma. [PDF]

Hematol Rep
Seidenfaden SC, Adams TG, Kamper P, Jespersen S, Pedersen MB.   +4 more
europepmc   +1 more source

Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma. [PDF]

Blood Adv
Baek G, Varma G, Yamshon S, van Besien H, Bartlett NL, Watkins M, Shah HR, Baron K, Merryman RW, Falade AS, Svoboda J, Prischak S, D'Angelo C, Lukowski JD, Advani RH, Yeung AH, Rosenberg M, Voutsinas J, Di M, Lynch R, Poh C, Raghunathan V, Shadman M, Smith S, Till BG, Ujjani C, Diefenbach CS, Gopal AK.   +27 more
europepmc   +1 more source

Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma. [PDF]

Cureus
Figueiredo F, Valido T, Chumbo C, Gomes G, Rocha M.   +4 more
europepmc   +1 more source

Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report. [PDF]

Front Oncol
Gao X, Wang X, Wang X, Cai H.
europepmc   +1 more source